Retracted: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis

    Glia
    |December 14, 2017
    PubMed

    Insights

    This study on metallothionein I+II expression in experimental autoimmune encephalomyelitis is retracted due to unreliable data. Discrepancies in animal models and numbers used make the findings questionable.

    Area of Science:

    • Neuroscience
    • Immunology
    • Biochemistry

    Background:

    • Metallothioneins (MTs) are proteins involved in cellular defense.
    • Their role in experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, was investigated.

    Purpose of the Study:

    • To examine the expression of metallothionein I+II.
    • To determine the role of these proteins in the pathogenesis of EAE.

    Main Methods:

    • The study involved experiments with animals to model EAE.
    • Analysis of metallothionein I+II expression was performed.

    Main Results:

    • The original article reported specific findings on metallothionein expression in EAE.
    • However, these results are now considered unreliable.

    Conclusions:

    • The original conclusions drawn from the study are invalidated.
    • The retraction highlights the importance of data integrity in scientific research.

    Related Concept Videos